Pieris Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 4 of 4 Posts
Pieris Pharmaceuticals Surges On The Stock Market After Agreement With Genentech
Article By: Admiral Markets Wednesday, May 26, 2021 9:39 AM EDT
During yesterday's session, Pieris Pharmaceuticals (PIRS) soared in the financial markets after reaching a collaboration agreement with Genentech, in an operation that could be valued at $1.4 billion.
In this article: PIRS
Read
4 Biotech Stocks That More Than Doubled This Year
Article By: Zacks Investment Research Saturday, December 23, 2017 7:50 PM EDT
The biotech industry has been on the comeback trail in 2017 after facing challenges including pricing pressure, rising competition, pipeline setbacks, pricing pressure, slowdown in growth of mature products and generic competition for key drugs.
In this article: JUNO, BLUE, XOMA, PBYI, PIRS, ALNY Also: CELG
Read
Pieris Pharmaceutical - Chart Of The Day
Article By: Jim Van Meerten Monday, July 10, 2017 6:51 PM EDT
Since the Trend Spotter signaled a buy in 5/4 the stock gained 67.51%.
In this article: PIRS
Read
Seven Biotech Names On The Upswing: 2016 Small-Cap Biotech Watchlist Update
Article By: The Life Sciences Report Wednesday, March 9, 2016 5:47 PM EDT
Biotech stocks—and the stock market in general—took a dive at the beginning of 2016, headed down on macroeconomic factors such as financial instability in China.
In this article: SGYP, CRMD, ORMP, SRNE, ARRY, PTIE, AGEN, GALE, PPHM, EVOK, ADMA, AKBA, KPTI, VSTM, AST, RXDX, AGTC, WVE, FATE, FLKS, PIRS, ABEO
Read
1 to 4 of 4 Posts